Type 2 Medication

|

10

Special Spotlight On Diabetes Prescription Drugs: Byetta (exenatide)

Medically reviewed by Victor Nguyen, PharmD, MS on July 10, 2019 — Written by Helen Marshall, BPharm, MRPharmS. Republished with permission …

AstraZeneca’s Brilinta with Aspirin Reduces Heart Related Events in Late Trials

AstraZeneca reported positive phase 3 trial results of Brilinta (ticagrelor) plus aspirin, which reduced the relative risk of cardiovascular events …

| | |

Farxiga Cuts Risk of Kidney Disease in Patients with Type 2 Diabetes

Astra Zeneca announced promising results of a phase 3 trial of Farxiga, which showed to reduce the progression of kidney disease or renal death in …

|

Victoza® Demonstrates Superiority in Reducing Blood Sugar in Children with T2D

Insulin maker, Novo Nordisk announced this week the results of a clinical trial which demonstrated the superiority of Victoza® (liraglutide) …

|

Genetics of Human Fat Cells Used to Predict Response to Anti-Diabetes Drugs

A new study from Penn Medicine shows that a person’s individual genetic variation may affect which medications are best to take. Drugs called …

|

Sky-rocketing Insulin Prices Prompt New Movement Across the U.S.

More than 7 million Americans are insulin dependent. And recent findings show that 1-in-4 Americans are rationing their insulin, a dangerous way …

| | |

Switching Course of Medication Linked to More Complications

For those with type 2 diabetes, changing course to sulfonylurea drugs to control blood sugar levels is associated with an increased risk of …

New Discovery Could Help Type 2 Diabetes Drug-Tolerance in Patients

A new discovery that may help millions of patients with type 2 diabetes tolerate their medications better was reported this week by researchers at …

| |

Insulin for Type 2 Diabetes

Many people with type 2 diabetes will eventually require insulin to keep their diabetes in control. In fact, most experts believe we wait too long in …

| | | | |

Type 2 Diabetes Medicines You Inject

1. Bydureon What is Bydureon? Bydureon is a member of the GLP-1 receptor agonist* family of medicines. Bydureon works in several places in the body, …

|